BioTime (BTX) Misses Q1 EPS by 5c

BioTime (NYSE: BTX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Ardent Health revises 2025 non-GAAP figures after SEC staff talks
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics